The Clinical Core is key to the functions of the Indiana Alzheimer Disease Center. It recruits, evaluates, diagnoses and characterizes groups of patients with Alzheimer Disease (AD) and with other forms of dementia. Patients with familial AD are identified and referred to the Indiana ADC National Cell Repository. It refers appropriate patients and at risk family members to the new Genetic Counseling and Testing Core. Clinical Core staff train, teach health care providers and educate the lay public and particularly the African American communities. Data from the Clinical Core are analyzed with the assistance of the statistics component of the Administrative Core. Subjects are followed longitudinally to death. Autopsy and neuropathological examinations are obtained through the Neuropathology Core. A clinicopathological correlation consensus is reached. The Clinical Core has particularly emphasized obtaining biological samples from patients including lymphocytes, plasma and cerebrospinal fluid, all of which are banked. This cohort of clinically and genetically well characterized subjects that have biological specimens are used to support research projects to determine the effects of genotype on clinical phenotypes, age of onset, associated biochemical abnormalities and response to drug therapy. We have also characterized and sampled age matched normal controls using the same methods. These subjects and samples are a valuable resource in the search for biological markers that have specificity for AD. Eventual autopsy obtained through the Neuropathology Core will help validate diagnosis in these subjects and is essential to prove specificity of potential markers for AD. Patients from the Clinical Core have also participated in neuropsychological and neuroimaging studies, as well as in a large number of investigational drug trials. The Clinical Core has and will continue to support development of investigating of other non-AD dementias including unique large kindreds with Gerstmann-Straussler-Scheinker Disease and multisystems atrophy with presenile dementia. A large cohort of elderly African Americans are followed by the Clinical Core with many volunteers participating in a variety of investigational studies. We will continue a strong educational effort to engage the African American community to develop further support for our research projects and to better communicate the importance of medical research and autopsy in understanding the causes and treatment of AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010133-09
Application #
6098336
Study Section
Project Start
1999-07-01
Project End
2000-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Miller, Jason E; Shivakumar, Manu K; Risacher, Shannon L et al. (2018) Codon bias among synonymous rare variants is associated with Alzheimer's disease imaging biomarker. Pac Symp Biocomput 23:365-376
Swinford, Cecily G; Risacher, Shannon L; Charil, Arnaud et al. (2018) Memory concerns in the early Alzheimer's disease prodrome: Regional association with tau deposition. Alzheimers Dement (Amst) 10:322-331
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Campbell, Noll L; Lane, Kathleen A; Gao, Sujuan et al. (2018) Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care. Pharmacotherapy 38:511-519

Showing the most recent 10 out of 604 publications